MISTY JAMES: Open Payments
NPI 1861914921 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$791 in 12 payments from 9 companies in 2025. Trend: 2023 $1,477 · 2024 $1,229 · 2025 $791
Food & beverage: $685Education: $106
| Company | Payments | Amount |
|---|---|---|
| Incyte Corporation | 3 | $249 |
| Agios Pharmaceuticals, Inc. | 1 | $137 |
| Adaptive Biotechnologies Corporation | 1 | $118 |
| Lilly USA, LLC | 1 | $106 |
| Astellas Pharma US Inc | 2 | $65 |
| SOBI, INC | 1 | $31 |
| Celgene Corporation | 1 | $31 |
| Syndax Pharmaceuticals, Inc. | 1 | $29 |
| Novartis Pharmaceuticals Corporation | 1 | $25 |
Products named: Niktimvo, PYRUKYND, clonoSEQ, Jakafi, Cresemba, Xospata, Gamifant, REBLOZYL.
Industry payments across TX — which companies pay providers there.
